MedPath

Study the effect of External applicalation of medicated powder on skin disease

Phase 3
Conditions
Health Condition 1: L858- Other specified epidermal thickening
Registration Number
CTRI/2024/05/066650
Lead Sponsor
Dr abhijeet sureshrao bhendekar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with clinical features of eka-kustha having signs and symptoms namely kandu ( itching), shushkta, vaivarnya( depigmentation), mastyashakalopama( silvery patch skin)

patients of both gender male and female, irrespective of of caste and sccioeconomic status.

Exclusion Criteria

Patient suffering from any chronic skin disease, immmune suppressed systemic disorder.

patient suffering from any other systemic disorder like tuberculosis, diabetes mellitus , HBsAg positive and know case of leprosy.

pregnant and lactating woman

Psoriatic arthritis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in PASI scoreTimepoint: 90 days
Secondary Outcome Measures
NameTimeMethod
Kandu( itching ) <br/ ><br>shushkta, <br/ ><br>vaivarnya ( depigmentation ) <br/ ><br>mastyashakaloptama( silvery patchy skin)Timepoint: 90 days
© Copyright 2025. All Rights Reserved by MedPath